Acutus Medical Q3 EPS $(0.52) Beats $(0.61) Estimate, Sales $5.24M Beat $4.83M Estimate
Portfolio Pulse from Benzinga Newsdesk
Acutus Medical reported Q3 earnings per share (EPS) of $(0.52), beating the analyst consensus estimate of $(0.61) by 14.75%. The company also reported quarterly sales of $5.24 million, surpassing the analyst consensus estimate of $4.83 million by 8.45%. Both EPS and sales figures represent significant increases over the same period last year.
November 08, 2023 | 9:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acutus Medical's Q3 results exceeded analyst expectations, which could positively impact the company's stock in the short term.
Acutus Medical's better-than-expected Q3 results could lead to increased investor confidence, potentially driving up the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100